Filana Therapeutics (FLNA) Non-Current Deferred Tax Liability (2010 - 2013)

Filana Therapeutics has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $437000.0 in Q3 2013.

• On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $437000.0 in Q3 2013; TTM through Sep 2013 was $437000.0, a N/A change from a year earlier, with the FY2012 full-year figure at $437000.0, changed 0.46% from the prior year.
• Non-Current Deferred Tax Liability was $437000.0 for Q3 2013 at Filana Therapeutics, roughly flat from $437000.0 in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $437000.0 in Q4 2012, with the low at $431000.0 in Q4 2010.
• Average Non-Current Deferred Tax Liability over 4 years is $435571.4, with a median of $437000.0 recorded in 2012.
• The sharpest annual moves came in 2011 and 2012: Non-Current Deferred Tax Liability grew 0.93% in 2011, then climbed 0.46% in 2012.
• Over 4 years, Non-Current Deferred Tax Liability stood at $431000.0 in 2010, then grew by 0.93% to $435000.0 in 2011, then advanced by 0.46% to $437000.0 in 2012, then changed by 0.0% to $437000.0 in 2013.
• The last three Non-Current Deferred Tax Liability figures came in at $437000.0 (Q3 2013), $437000.0 (Q2 2013), and $437000.0 (Q1 2013), per Business Quant data.